45 years of tetracycline post exposure prophylaxis for STIs and the risk of tetracycline resistance: a systematic review and meta-analysis

BMC Infect Dis. 2024 Apr 4;24(1):376. doi: 10.1186/s12879-024-09275-3.

Abstract

There is considerable interest in the use of doxycycline post exposure prophylaxis (PEP) to reduce the incidence of bacterial sexually transmitted infections (STIs). An important concern is that this could select for tetracycline resistance in these STIs and other species. We searched PubMed and Google Scholar, (1948-2023) for randomized controlled trials comparing tetracycline PEP with non-tetracycline controls. The primary outcome was antimicrobial resistance (AMR) to tetracyclines in all bacterial species with available data. Our search yielded 140 studies, of which three met the inclusion criteria. Tetracycline PEP was associated with an increasedprevalence of tetracycline resistance in Neisseria gonorrhoeae, but this effect was not statistically significant (Pooled OR 2.3, 95% CI 0.9-3.4). PEP had a marked effect on the N. gonorrhoeae tetracycline MIC distribution in the one study where this was assessed. Prophylactic efficacy was 100% at low MICs and 0% at high MICs. In the one study where this was assessed, PEP resulted in a significant increase in tetracycline resistance in commensal Neisseria species compared to the control group (OR 2.9, 95% CI 1.5-5.5) but no significant effect on the prevalence of tetracycline resistance in Staphylococcus aureus. The available evidence suggests that PEP with tetracyclines could be associated with selecting tetracycline resistance in N. gonorrhoeae and commensal Neisseria species.

Keywords: Doxycycline PEP; AMR; Gonorrhoea; Minocycline; PrEP; Tetracycline.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Gonorrhea* / drug therapy
  • Gonorrhea* / epidemiology
  • Gonorrhea* / prevention & control
  • Humans
  • Microbial Sensitivity Tests
  • Mitomycin / therapeutic use
  • Neisseria gonorrhoeae
  • Post-Exposure Prophylaxis
  • Sexually Transmitted Diseases*
  • Tetracycline / pharmacology
  • Tetracycline / therapeutic use
  • Tetracycline Resistance
  • Tetracyclines / pharmacology
  • Tetracyclines / therapeutic use

Substances

  • Tetracycline
  • Anti-Bacterial Agents
  • Tetracyclines
  • Mitomycin